| Company Name: |
Nextpeptide Inc |
| Tel: |
+86-0571-81612335 +8613336028439 |
| Email: |
sales@nextpeptide.com |
|
| | Mal-PEG1-Bromide Basic information |
| Product Name: | Mal-PEG1-Bromide | | Synonyms: | Mal-PEG1-Bromide;1H-Pyrrole-2,5-dione, 1-[2-(2-bromoethoxy)ethyl]-;1-[2-(2-bromoethoxy)ethyl]-2,5-dihydro-1H-pyrrole-2,5-dione;1-(2-(2-bromoethoxy)ethyl)-1H-pyrrole-2,5-dione | | CAS: | 1823885-81-9 | | MF: | C8H10BrNO3 | | MW: | 248.07 | | EINECS: | | | Product Categories: | | | Mol File: | 1823885-81-9.mol |  |
| | Mal-PEG1-Bromide Chemical Properties |
| Boiling point | 358.1±22.0 °C(Predicted) | | density | 1.588±0.06 g/cm3(Predicted) | | solubility | Soluble in DMSO, DCM, DMF | | pka | -2.35±0.20(Predicted) |
| | Mal-PEG1-Bromide Usage And Synthesis |
| Description | Mal-PEG1-Bromide contains a maleimide group and bromide group. The maleimide group will react with a thiol group to form a covalent bond, enabling the connection of biomolecule with a thiol. The bromide (Br) is a very good leaving group for nucleophilic substitution reactions. | | Uses | Mal-PEG1-bromide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | | IC 50 | PEGs | | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
| | Mal-PEG1-Bromide Preparation Products And Raw materials |
|
|
Tag:Mal-PEG1-Bromide(1823885-81-9)
Related Product Information
|
|
Mal-PEG3-PFP
Mal-amido-PEG7-acid
Mal-PEG12-acid
4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73,76,79,82,85-Octacosaoxa-88-azahennonacontanoic acid, 91-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-89-oxo-, 2,5-dioxo-1-pyrrolidinyl ester
Mal-PEG3-alcohol
Mal-amido-PEG8-Val-Gly
Mal-PEG6-PFP
INDEX NAME NOT YET ASSIGNED
Mal-PEG4-Acid
Mal-PEG5-PFP
Mal-PEG3-Val-Cit-PAB-PNP
Mal-PEG3-alcohol
Mal-PEG4-PFP
Maleimido-Tri(Ethylene Glycol)-Propionic Acid
Mal-amido-PEG12-TFP ester
Mal-amido-PEG8-val-gly-PAB-OH
Mal-PEG3-Val-Cit-PAB-OH
Mal-PEG4-NHS ester
|